Xencor, Inc Increase (Decrease) in Prepaid Expense and Other Assets
Xencor, Inc (XNCR) reported Increase (Decrease) in Prepaid Expense and Other Assets of $1.43 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-05
- Xencor, Inc increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$738.00K, a 147.52% decline year-over-year.
- Xencor, Inc increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $2.17M.
- Xencor, Inc increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$680.00K, a 502.37% decline year-over-year.
- Xencor, Inc increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$5.26M.
- Xencor, Inc increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$9.44M.
- Xencor, Inc increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$159.00K.
- Xencor, Inc increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$5.10M.
- Xencor, Inc increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$634.00K, a 104.66% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$738.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $1.43M 10-Q · filed 2026-08-05 | $747.00K derived: sum of 3 quarters · filed 2026-08-05 | -$4.51M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | $2.17M 10-Q · filed 2026-05-06 | $1.49M derived: sum of 2 quarters · filed 2026-05-06 | -$3.77M derived: sum of 3 quarters · filed 2026-05-06 | -$2.22M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | -$680.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$5.94M derived: sum of 2 quarters · filed 2026-02-25 | -$4.38M derived: sum of 3 quarters · filed 2026-08-05 | -$9.44M 10-K · filed 2026-02-25 | ||||
| 2025-09-30 | -$5.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$3.70M derived: sum of 2 quarters · filed 2026-08-05 | -$8.76M 10-Q · filed 2025-11-05 | -$8.59M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | $1.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$3.50M 10-Q · filed 2026-08-05 | -$3.33M derived: sum of 3 quarters · filed 2026-08-05 | -$8.57M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | -$5.06M 10-Q · filed 2026-05-06 | -$4.89M derived: sum of 2 quarters · filed 2026-05-06 | -$10.12M derived: sum of 3 quarters · filed 2026-05-06 | -$3.24M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | $169.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$5.07M derived: sum of 2 quarters · filed 2026-02-25 | $1.81M derived: sum of 3 quarters · filed 2026-02-25 | -$159.00K 10-K · filed 2026-02-25 | ||||
| 2024-09-30 | -$5.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $1.65M derived: sum of 2 quarters · filed 2025-11-05 | -$328.00K 10-Q · filed 2025-11-05 | $1.85M 10-Q · filed 2024-11-06 | -$3.84M derived: sum of 4 quarters · filed 2026-02-25 | |||
| 2024-06-30 | $6.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $4.91M 10-Q · filed 2025-08-06 | $5.69M 10-Q · filed 2024-08-05 | $1.40M derived: sum of 3 quarters · filed 2026-02-25 | $931.00K derived: sum of 4 quarters · filed 2026-02-25 | |||
| 2024-03-31 | -$1.97M 10-Q · filed 2025-05-07 | -$1.56M 10-Q · filed 2024-05-09 | -$5.49M derived: sum of 2 quarters · filed 2026-02-25 | -$5.95M derived: sum of 3 quarters · filed 2026-02-25 | -$5.87M derived: sum of 4 quarters · filed 2026-02-25 | |||
| 2023-12-31 | -$3.51M derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-02-25 | -$3.98M derived: sum of 2 quarters · filed 2026-02-25 | -$3.90M derived: sum of 3 quarters · filed 2026-02-25 | -$5.10M 10-K · filed 2026-02-25 | ||||
| 2023-09-30 | -$465.00K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2025-02-24 | -$388.00K derived: sum of 2 quarters · filed 2025-02-24 | -$1.59M 10-Q/A · filed 2025-02-24 | -$1.20M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-06-30 | $77.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2025-02-24 | -$1.13M 10-Q/A · filed 2025-02-24 | -$730.00K derived: sum of 3 quarters · filed 2025-02-27 | $2.42M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-03-31 | -$1.20M 10-Q/A · filed 2025-02-24 | -$807.00K derived: sum of 2 quarters · filed 2025-02-27 | $2.35M derived: sum of 3 quarters · filed 2025-02-27 | -$932.00K derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2022-12-31 | $397.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $3.55M derived: sum of 2 quarters · filed 2025-02-27 | $272.00K derived: sum of 3 quarters · filed 2025-02-27 | -$634.00K 10-K · filed 2025-02-27 | ||||
| 2022-09-30 | $3.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$125.00K derived: sum of 2 quarters · filed 2023-11-08 | -$1.03M 10-Q · filed 2023-11-08 | $1.96M derived: sum of 4 quarters · filed 2025-02-24 | ||||
| 2022-06-30 | -$3.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$4.18M 10-Q · filed 2023-08-03 | -$1.19M derived: sum of 3 quarters · filed 2025-02-24 | $4.48M derived: sum of 4 quarters · filed 2025-02-24 | ||||
| 2022-03-31 | -$906.00K 10-Q · filed 2023-05-08 | $2.09M derived: sum of 2 quarters · filed 2025-02-24 | $7.76M derived: sum of 3 quarters · filed 2025-02-24 | $9.19M derived: sum of 4 quarters · filed 2025-02-24 | ||||
| 2021-12-31 | $2.99M derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-02-24 | $8.66M derived: sum of 2 quarters · filed 2025-02-24 | $10.09M derived: sum of 3 quarters · filed 2025-02-24 | $13.59M 10-K/A · filed 2025-02-24 | $13.15M 10-K · filed 2022-02-24 | |||
| 2021-09-30 | $5.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $7.10M derived: sum of 2 quarters · filed 2022-11-07 | $10.60M 10-Q · filed 2022-11-07 | $10.16M 10-Q · filed 2021-11-08 | $11.14M derived: sum of 4 quarters · filed 2023-02-27 | |||
| 2021-06-30 | $1.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $4.93M 10-Q · filed 2022-08-03 | $4.87M 10-Q · filed 2021-08-04 | $5.47M derived: sum of 3 quarters · filed 2023-02-27 | $8.26M derived: sum of 4 quarters · filed 2023-02-27 | |||
| 2021-03-31 | $3.50M 10-Q · filed 2022-05-05 | $3.44M 10-Q · filed 2021-05-05 | $4.04M derived: sum of 2 quarters · filed 2023-02-27 | $6.83M derived: sum of 3 quarters · filed 2023-02-27 | $7.74M derived: sum of 4 quarters · filed 2023-02-27 | |||
| 2020-12-31 | $541.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $3.33M derived: sum of 2 quarters · filed 2023-02-27 | $4.24M derived: sum of 3 quarters · filed 2023-02-27 | $4.17M 10-K · filed 2023-02-27 | ||||
| 2020-09-30 | $2.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $3.70M derived: sum of 2 quarters · filed 2021-11-08 | $3.63M 10-Q · filed 2021-11-08 | $2.64M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-06-30 | $914.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $843.00K 10-Q · filed 2021-08-04 | -$142.00K derived: sum of 3 quarters · filed 2022-02-24 | -$3.92M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-03-31 | -$71.00K 10-Q · filed 2021-05-05 | -$1.06M derived: sum of 2 quarters · filed 2022-02-24 | -$4.83M derived: sum of 3 quarters · filed 2022-02-24 | -$2.96M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2019-12-31 | -$985.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$4.76M derived: sum of 2 quarters · filed 2022-02-24 | -$2.89M derived: sum of 3 quarters · filed 2022-02-24 | -$3.83M 10-K · filed 2022-02-24 | ||||
| 2019-09-30 | -$3.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$1.90M derived: sum of 2 quarters · filed 2020-11-06 | -$2.84M 10-Q · filed 2020-11-06 | -$4.61M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2019-06-30 | $1.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $932.00K 10-Q · filed 2020-08-05 | -$834.00K derived: sum of 3 quarters · filed 2021-02-24 | -$767.00K derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2019-03-31 | -$942.00K 10-Q · filed 2020-05-08 | -$2.71M derived: sum of 2 quarters · filed 2021-02-24 | -$2.64M derived: sum of 3 quarters · filed 2021-02-24 | $2.78M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2018-12-31 | -$1.77M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | -$1.70M derived: sum of 2 quarters · filed 2021-02-24 | $3.73M derived: sum of 3 quarters · filed 2021-02-24 | $4.77M 10-K · filed 2021-02-24 | ||||
| 2018-09-30 | $67.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $5.49M derived: sum of 2 quarters · filed 2019-11-05 | $6.54M 10-Q · filed 2019-11-05 | $5.27M derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2018-06-30 | $5.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $6.47M 10-Q · filed 2019-08-07 | $5.20M derived: sum of 3 quarters · filed 2020-02-25 | $4.45M derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2018-03-31 | $1.04M 10-Q · filed 2019-05-09 | -$223.00K derived: sum of 2 quarters · filed 2020-02-25 | -$979.00K derived: sum of 3 quarters · filed 2020-02-25 | $2.28M derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2017-12-31 | -$1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | -$2.02M derived: sum of 2 quarters · filed 2020-02-25 | $1.24M derived: sum of 3 quarters · filed 2020-02-25 | $2.71M 10-K · filed 2020-02-25 | ||||
| 2017-09-30 | -$756.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | $2.51M derived: sum of 2 quarters · filed 2018-11-05 | $3.97M 10-Q · filed 2018-11-05 | $3.38M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-06-30 | $3.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $4.73M 10-Q · filed 2018-08-07 | $4.14M derived: sum of 3 quarters · filed 2019-02-26 | $5.40M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-03-31 | $1.47M 10-Q · filed 2018-05-07 | $877.00K derived: sum of 2 quarters · filed 2019-02-26 | $2.13M derived: sum of 3 quarters · filed 2019-02-26 | $2.48M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2016-12-31 | -$588.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $669.00K derived: sum of 2 quarters · filed 2019-02-26 | $1.02M derived: sum of 3 quarters · filed 2019-02-26 | $1.70M 10-K · filed 2019-02-26 | ||||
| 2016-09-30 | $1.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $1.60M derived: sum of 2 quarters · filed 2017-11-08 | $2.29M 10-Q · filed 2017-11-08 | $2.64M derived: sum of 4 quarters · filed 2018-02-28 | ||||
| 2016-06-30 | $348.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $1.03M 10-Q · filed 2017-08-07 | $1.38M derived: sum of 3 quarters · filed 2018-02-28 | $1.56M derived: sum of 4 quarters · filed 2018-02-28 | ||||
| 2016-03-31 | $683.00K 10-Q · filed 2017-05-10 | $1.04M derived: sum of 2 quarters · filed 2018-02-28 | $1.21M derived: sum of 3 quarters · filed 2018-02-28 | $1.61M derived: sum of 4 quarters · filed 2018-02-28 | ||||
| 2015-12-31 | $353.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $530.00K derived: sum of 2 quarters · filed 2018-02-28 | $926.00K derived: sum of 3 quarters · filed 2018-02-28 | $1.07M 10-K · filed 2018-02-28 | ||||
| 2015-09-30 | $177.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $573.00K derived: sum of 2 quarters · filed 2016-11-02 | $715.00K 10-Q · filed 2016-11-02 | $726.00K derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-06-30 | $396.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $538.00K 10-Q · filed 2016-08-03 | $534.00K 10-Q · filed 2015-08-05 | $549.00K derived: sum of 3 quarters · filed 2017-03-01 | $311.00K derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2015-03-31 | $142.00K 10-Q · filed 2016-05-02 | $153.00K derived: sum of 2 quarters · filed 2017-03-01 | -$85.00K derived: sum of 3 quarters · filed 2017-03-01 | $116.00K derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2014-12-31 | $11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$227.00K derived: sum of 2 quarters · filed 2017-03-01 | -$26.00K derived: sum of 3 quarters · filed 2017-03-01 | $73.00K 10-K · filed 2017-03-01 | ||||
| 2014-09-30 | -$238.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | -$37.00K derived: sum of 2 quarters · filed 2015-11-04 | $62.00K 10-Q · filed 2015-11-04 | -$1.03M derived: sum of 4 quarters · filed 2016-03-08 | ||||
| 2014-06-30 | $201.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $300.00K 10-Q · filed 2015-08-05 | -$796.00K derived: sum of 3 quarters · filed 2016-03-08 | $116.00K derived: sum of 4 quarters · filed 2016-03-08 | ||||
| 2014-03-31 | $99.00K 10-Q · filed 2015-05-05 | -$997.00K derived: sum of 2 quarters · filed 2016-03-08 | -$85.00K derived: sum of 3 quarters · filed 2016-03-08 | |||||
| 2013-12-31 | -$1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-08 | -$184.00K derived: sum of 2 quarters · filed 2016-03-08 | -$115.00K 10-K · filed 2016-03-08 | |||||
| 2013-09-30 | $912.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $981.00K 10-Q · filed 2014-11-10 | ||||||
| 2013-06-30 | $69.00K 10-Q · filed 2014-08-01 | |||||||
| 2012-12-31 | $90.00K 10-K · filed 2015-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |